Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: a systematic review and meta‐analysis
Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearan... : Hepatology Steatosis,
HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis …
HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis …
[HTML][HTML] Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis
Methods We searched 4 databases from inception to December 2021 and pooled study-
level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …
level estimates using a random-effects model for conventional MA. For IPDMA, we evaluated …
Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
Background Steatotic liver disease (SLD) is an emerging liver disease that has been
associated with an increased risk for hepatocellular carcinoma (HCC). The impact of …
associated with an increased risk for hepatocellular carcinoma (HCC). The impact of …
Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis
L Liu, H Li, Y Zhang, J Zhang, Z Cao - Heliyon, 2023 - cell.com
Hepatitis B virus (HBV) infection is still one kind of the infectious diseases that seriously
threaten human health. Nonalcoholic fatty liver disease (NAFLD) has become the most …
threaten human health. Nonalcoholic fatty liver disease (NAFLD) has become the most …
[HTML][HTML] Achieving chronic hepatitis B functional cure: Factors and potential mechanisms
J Zheng, Z Wang, L Huang, Z Qiu, Y Xie, S Jiang… - Virus Research, 2025 - Elsevier
Chronic hepatitis B (CHB) is a significant global health issue affecting approximately 254
million individuals worldwide. Achieving the loss of hepatitis B surface antigen (HBsAg) …
million individuals worldwide. Achieving the loss of hepatitis B surface antigen (HBsAg) …
[HTML][HTML] The Association Between Weight Loss and Hepatitis B Surface Antigen Seroclearence in Chronic Hepatitis B Patients
Background: In chronic hepatitis B (CHB) patients, hepatitis B surface antigen (HBsAg)
seroclearance is the main target of therapy and is rarely observed. Objectives: This study …
seroclearance is the main target of therapy and is rarely observed. Objectives: This study …
非酒精性脂肪性肝病对乙型肝炎病毒感染影响的研究进展
张亦凡， 王俊青， 郭斯敏 - 上海交通大学学报(医学版), 2023 - xuebao.shsmu.edu.cn
慢性乙型肝炎(chronic hepatitis B, CHB) 是由乙型肝炎病毒(hepatitis B virus, HBV)
持续感染所致的一种传染性疾病, 在世界范围内有较高的流行率. 非酒精性脂肪性肝病(non …
持续感染所致的一种传染性疾病, 在世界范围内有较高的流行率. 非酒精性脂肪性肝病(non …
Research progress of the impact of nonalcoholic fatty liver disease on chronic hepatitis B infection
BJE Chin, SON Peng, Z Yifan… - Journal of Shanghai …, 2023 - xuebao.shsmu.edu.cn
Chronic hepatitis B (CHB) is an infectious disease caused by persistent infection with the
hepatitis B virus (HBV) and is highly prevalent worldwide. Non-alcoholic fatty liver disease …
hepatitis B virus (HBV) and is highly prevalent worldwide. Non-alcoholic fatty liver disease …